Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers

Springer Science and Business Media LLC - Tập 18 Số 3 - Trang 721-728 - 2012
Anna Krześlak1, Katarzyna Wójcik‐Krowiranda2, Ewa Forma3, Paweł Jóźwiak3, Hanna Romanowicz4, Andrzej Bieńkiewicz2, Magdalena Bryś3
1Department of Cytobiochemistry, University of Lodz, Pomorska 141/143, 90-236, Lodz, Poland
2Medical University Of Lodz
3University of Lódż
4Polish Mother’s Memorial Hospital—Research Institute

Tóm tắt

Từ khóa


Tài liệu tham khảo

Young CD, Anderson SM (2008) Sugar and fat—that’s where it’s at: metabolic changes in tumors. Breast Cancer Res 10:202

Ganapathy V, Thangaraju M, Prasad PD (2009) Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 121:29–40

Warburg O (1930) The metabolizm of tumors. Constable, London

Warburg O (1956) On the origin of cancer cells. Science 123:309–314

Thorens B, Mueckler M (2010) Glucose transporters in the 21st Century. Am J Physiol Endocrinol Metab 298:E141–E145

Macheda ML, Rogers S, Best JD (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202:654–662

Younes M, Brown RW, Stephenson M, Gondo M, Cagle PT (1997) Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer 80:1046–1051

Kawamura T, Kusakabe T, Sugino T et al (2001) Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer 92:634–641

Haber RS, Rathan A, Weiser KR et al (1998) GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer 83:34–40

Sakashita M, Aoyama N, Minami R et al (2001) Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features. Eur J Cancer 37:204–209

Kalir T, Wang BY, Goldfischer M et al (2002) Immunohistochemical staining of GLUT1 in benign, borderline and malignant ovarian epithelia. Cancer 94:1078–1082

Boado RJ, Black KL, Pardridge WM (1994) Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors. Mol Brain Res 27:51–57

Estilo CL, O-charoenrat P, Talbot S et al (2009) Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 9:11

Ayala FR, Rocha RM, Carvalho KC et al (2010) GLUT3 as potential prognostic markers for oral squamous cell carcinoma. Molecules 15:2374–2387

Baer S, Casaubon L, Schwartz MR, Marcogliese A, Younes M (2002) Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival. Laryngoscope 112:393–396

Matsuzu K, Segade F, Matsuzu U et al (2004) Differential expression of glucose transporters in normal and pathological thyroid tissue. Thyroid 14:806–812

Tsukioka M, Matsumoto Y, Noriyuki M et al (2007) Expression of glucose transporters in epithelial ovarian carcinoma: correlation with clinical characteristics and tumor angiogenesis. Oncol Rep 8:361–367

Rudlowski C, Moser M, Becker AJ et al (2004) GLUT1 mRNA and protein expression in ovarian borderline tumors and cancer. Oncology 66:404–410

Tavassoli FA, Devilee P (2003) World Health Organization classification of tumours. Pathology & genetics of tumours of the breast and female genital organs, vol 1. IARC, Lyon, pp 217–232

Goldman NA, Katz EB, Glenn AS et al (2006) GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma. Mod Pathol 19:1429–1436

Wang BY, Kalir T, Sabo E et al (2000) Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia. Cancer 88:2774–2781

Younes M, Brown RW, Mody DR, Fernandez L, Laucirica R (1995) GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res 15:2895–2898

Kang SS, Chun YK, Hur MH et al (2002) Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn J Cancer Res 93:1123–1128

Schmidt M, Voelker HU, Kapp M et al (2010) Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK. J Cancer Res Clin Oncol 36:219–225

Ravazoula P, Batistatou A, Aletra C et al (2003) Immunohistochemical expression of glucose transporter Glut1 and cyclin D1 in breast carcinomas with negative lymph nodes. Eur J Gynaecol Oncol 24:544–546

Younes M, Lechago LV, Somoano JR, Mosharaf M, Lechago J (1997) Immunohistochemical detection of Glut3 in human tumors and normal tissues. Anticancer Res 17:2747–2750

Godoy A, Ulloa V, Rodríguez F et al (2006) Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J Cell Physiol 207:614–627

Rivenzon-Segal D, Boldin-Adamsky S, Seger D, Seger R, Degani H (2003) Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer. Int J Cancer 107:177–182